Table 1.
Sepsis patients | |
| |
Number of patients | 104 |
Mean age | 66 ± 12 |
Male | 59 |
Female | 45 |
Sepsis | 63 |
Gram-positive | 26 |
Gram-negative | 34 |
Yeast | 3 |
Severe sepsis/septic shock | 41 |
Gram-positive | 15 |
Gram- negative | 19 |
Yeast | 7 |
APACHE II score | |
Sepsis 16.2 (surv.: 15.4; nonsurv.: 20.2) | |
Severe sepsis 19.6 (surv.: 18.5; nonsurv.: 20.7) | |
SOFA score | |
Sepsis 3.6 (surv.: 2.6; nonsurv.: 5.2) | |
Severe sepsis 6.3 (surv.: 5; nonsurv.: 7) | |
With comorbidities | |
Diabetes | 8 |
Malignancy | 48 |
Hematological malignancies | 13 |
Cardiovascular disease | 10 |
Gastrointestinal disease | 6 |
Autoimmune disease | 4 |
Renal failure | 5 |
Others | 12 |
Site of primary infection | |
Pneumoniae | 9 |
Intra-abdominal | 29 |
Urinary tract infection | 20 |
CVC colonization | 14 |
Soft tissue | 11 |
Unknown | 21 |
| |
SIRS patients | |
| |
Number of patients | 51 |
Mean age | 60 ± 10 |
Male | 27 |
Female | 24 |
APACHE II score | |
7.9 (surv.: 7.1; nonsurv.: 9.6) | |
With comorbidities | |
Diabetes | 2 |
Malignancy | 15 |
Hematological malignancies | 36 |
Cardiovascular disease | 2 |
Gastrointestinal disease | 4 |
Autoimmune disease | 2 |
Hepatic failure | 1 |
Others | 4 |
| |
Healthy controls | |
| |
Number of patients | 50 |
Mean age | 65 ± 12 |
Male | 35 |
Female | 15 |
surv.: survivor; nonsurv.: nonsurvivor.